클로부티놀 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)
Clobutinol Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드 : 1815154
리서치사 : Lucintel
발행일 : 2025년 09월
페이지 정보 : 영문 150 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,850 ₩ 5,558,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 ₩ 6,713,000
PDF (2 Users License) help
PDF 보고서를 동일 사업장에서 2명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,350 ₩ 7,724,000
PDF (5 Users License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,050 ₩ 10,178,000
PDF (Corporate License) help
PDF 보고서를 기업 내 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계 클로부티놀 시장의 미래는 의약품 시장과 화학제품 시장에서의 기회로 유망합니다. 세계 클로부티놀 시장은 2025-2031년 동안 CAGR 6%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 제약 연구 개발에서 특수 화학 시약에 대한 수요 증가와 틈새 화학 산업에서 정밀 화학 및 중간체에 대한 수요 증가입니다.

클로부티놀 시장의 새로운 동향

클로부티놀 시장은 안전성을 이유로 전 세계적으로 의약품으로 적용이 보류되어 치료제로서의 확대나 신규 용도 등 전통적인 '새로운 트렌드'는 보이지 않고 있습니다. 오히려 주목해야 할 '트렌드'는 의약품의 안전성에 대한 후향적 사용 사례, 비제약 분야에서의 잠재적(매우 제한적인) 응용, 또는 약리학적 프로파일에 대한 학술적 연구 등이 될 수 있습니다. 주요 동향은 주류 의약품 시장에서 여전히 사라지고 있다는 점과 철수를 통해 얻은 교훈입니다.

이러한 추세와 맞물려 클로부티놀은 과거 안전성에 대한 우려로 인해 존재하지 않았던 의약품 시장으로 재정의되고 있습니다. 치료용에서 벗어나 의약품 안전에 대한 일반적 교훈, 약물 대체품, 매우 전문적인 비의료적 용도로 관심이 옮겨가고 있습니다. 이 시장의 주요 특징으로는 퇴출과 이에 따른 안전한 대체품의 필요성, 그리고 제약 부문의 엄격한 규제에 대한 대처가 있습니다.

클로부티놀 시장의 최근 동향

클로부티놀 시장은 최근 극적이고 결정적인 변화를 목격했으며, 특히 전 세계적으로 의약품 용도에서의 철수로 정의되는 극적인 변화를 목격했습니다. 이러한 조치는 심장 안전성 우려 가능성을 입증한 임상 증거의 개정에 대한 직접적인 반응이었습니다. 이러한 변화는 전 세계 규제 당국과 제약회사들의 환자 보호에 대한 강한 관심의 표현이며, 클로부티놀의 상업적 잠재력과 치료 기능에 대한 철저한 재평가를 불러일으켰습니다.

이러한 사건들은 클로부티놀의 지위를 의약품에서 의약품 시장에 부분적으로 존재하지 않는 의약품으로 근본적으로 변화시킴으로써 클로부티놀 시장에 누적적인 영향을 미쳤습니다. 그 결과, 클로부티놀은 전 세계적으로 판매가 중단되었고, 진해제 시장의 초점은 더 안전한 대체 약물과 다른 치료법으로 옮겨졌습니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 유형별 클로부티놀 시장

제5장 용도별 클로부티놀 시장

제6장 지역 분석

제7장 북미의 클로부티놀 시장

제8장 유럽의 클로부티놀 시장

제9장 아시아태평양의 클로부티놀 시장

제10장 기타 지역의 클로부티놀 시장

제11장 경쟁 분석

제12장 기회와 전략 분석

제13장 밸류체인 전체에 걸친 주요 기업 개요

제14장 부록

KSM
영문 목차

영문목차

The future of the global clobutinol market looks promising with opportunities in the medicine and chemical markets. The global clobutinol market is expected to grow with a CAGR of 6% from 2025 to 2031. The major drivers for this market are the rising demand for specialized chemical reagents in pharmaceutical research & development and the increasing need for fine chemicals & intermediates in niche chemical industries.

Emerging Trends in the Clobutinol Market

The clobutinol market, having been withdrawn globally from medicinal application on grounds of safety, is not witnessing conventional "emerging trends" in terms of expansion or novel applications as a therapeutic. Rather, any notable "trends" would pertain to being a retrospective case study on drug safety, its potential (extremely limited) applications in non-pharmaceutical areas, or scholarly investigation of its pharmacological profile. The main trend is its ongoing absence from mainstream pharmaceutical markets and the lessons that were learned from withdrawal.

All these trends together are redefining the Clobutinol as a nonexistent drug market through past safety concerns. The attention has moved away from its therapeutic use and towards general lessons in drug safety, alternatives to medication, and extremely specialized non-medical applications. The market is mainly characterized by its withdrawal and the resulting necessity for safer alternatives and rigorous regulatory efforts within the pharmaceutical sector.

Recent Developments in the Clobutinol Market

The clobutinol market has witnessed dramatic and conclusive recent changes, particularly defined by its worldwide withdrawal from pharmaceutical application. These measures were a direct reaction to revised clinical evidence that established possible cardiac safety concerns. The changes indicate an intense focus on patient protection within world regulatory agencies and pharmaceutical corporations, which resulted in a thorough re-assessment of Clobutinol's commercial potential and therapeutic function.

These events have cumulatively affected the clobutinol market by fundamentally changing its status from a medicinal to a drug that is partially non-existent on pharmaceutical markets. The general effect is an affirmation of the absolutely foremost significance of drug safety, resulting in its global withdrawal and a consequent change of focus in the antitussive market towards safer alternatives and other therapeutic options.

Strategic Growth Opportunities in the Clobutinol Market

The growth prospects in the clobutinol market are in effect nonexistent for its past use as a cough suppressant because of its worldwide withdrawal for cardiac safety issues. Hence, talking about "growth opportunities by application" in the conventional sense would not be accurate. Any "opportunities" involving Clobutinol would be in ancillary areas like research, regulatory insights, or highly niche non-medical applications, and not a profitable pharmaceutical market.

These extremely specialized "opportunities" are affecting the Clobutinol by consolidating its position as a drug that has been withdrawn from general medical use because of safety issues. The effect is one of redirection from its direct therapeutic use to its use as a research tool, a classic case study, and an impetus for enhancing drug safety and regulatory habits in the wider pharmaceutical community.

Clobutinol Market Driver and Challenges

Due to the withdrawal of Clobutinol market from general sale in most markets on safety grounds, traditional analysis of "drivers and challenges" for its market in terms of expansion or commercial viability is not fitting. Rather, the "drivers" would be reasons for its withdrawal, and the "challenges" would be the effects of that withdrawal or the reasons it is no longer available on the market.

The factors responsible for driving the clobutinol market include:

1. Risk Discovery of Cardiac Arrhythmia: The strongest incentive for the market downturn was the discovery of a possible risk of cardiac arrhythmia, i.e., QT prolongation, by way of post-market monitoring and fresh clinical trials. The safety issue had a direct bearing on the regulatory warning that followed withdrawal. The implication here is a shift in the risk-benefit paradigm of the drug, wherein its medicinal use is no longer viable.

2. Proactive Regulatory Actions and Patient Safety Emphasis: The regulatory agencies, especially in Europe, acted quickly and firmly, issuing warnings and withdrawing marketing authorizations based on the new safety information. This proactive action by regulators, putting patient safety above availability in the market, was a key factor in the withdrawal of Clobutinol. This suggests a strengthening of high-quality drug safety measures across the world.

3. Voluntary Withdrawal by the Maker (Boehringer Ingelheim): The voluntary action by Boehringer Ingelheim, the main maker, to withdraw Clobutinol products from all markets was critical. This action, on their own safety evaluations, showed corporate responsibility and facilitated the removal of the drug. The inference is that drug makers tend to act ahead of or in coordination with regulatory action when there are major safety issues.

4. Availability of Safer Alternative Antitussives: The marketplace had plenty of other safe and effective cough suppressants to choose from, including dextromethorphan and codeine (where still on the market and utilized for cough). Availability of these alternatives would mean that de-authorization of Clobutinol did not leave an unmet medical need. The suggestion would be that the marketplace readily accommodated the loss of Clobutinol without excessive cough management disruption.

5. Increased Pharmacovigilance and Post-Market Monitoring: The Clobutinol example was a high-profile instance of the necessity of ongoing pharmacovigilance and post-market monitoring for any drug, including ones that have been in use for many years. The system successfully detected a severe safety problem that did not manifest during early trials. The implication is an increased strengthening of drug safety monitoring around the world, resulting in earlier identification of possible issues.

Challenges in the clobutinol market are:

1. Non-existent Commercial Market for Medicinal Use: The main problem is that there practically does not exist any legitimate commercial market for Clobutinol as a cough suppressant in most developed nations as it has been withdrawn. Demand would be very niche or illegal. The implication is that previous producers and sellers have closed down any operations on its medicinal product, and hence, conventional market analysis does not apply.

2. Reputational Harm and Loss of Trust: A withdrawal of a highly popular drug because of safety issues can result in reputational harm to the original company and may also cause a loss of public trust in drug safety procedures, even though ultimately the withdrawal proved to be for the good. The connotation is a lasting test for the pharmaceutical sector to keep public trust in drug safety and regulation intact.

3. Healthcare Providers and Patients Disruption (during withdrawal): Although alternatives may have been available, the abrupt withdrawal of a widely used or over-the-counter drug might temporarily have disrupted healthcare providers' prescribing practices and patients who were habituated to using it. The implication here is the real-world difficulty of managing drug discontinuations in practice, even with safety justification.

In summary, the analysis of the clobutinol market is special insofar as its course was dominated by safety issues. Its discovery of risk to cardiac arrhythmia, anticipatory regulatory action, and voluntary withdrawal by the manufacturer were dominant "drivers" to its rapid fall from medical usage. Thus, the "challenges" presently hinge on its non-existent market for commercial purposes, the remaining impact of a withdrawn drug on industry image, and lessons learned in pharmacovigilance. This case highlights the utmost significance of patient safety within the pharmaceutical business, essentially transforming the existence of the drug to near zero.

List of Clobutinol Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clobutinol companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clobutinol companies profiled in this report include-

Clobutinol Market by Segment

The study includes a forecast for the global clobutinol market by type, application, and region.

Clobutinol Market by Type [Value from 2019 to 2031]:

Clobutinol Market by Application [Value from 2019 to 2031]:

Clobutinol Market by Region [Value from 2019 to 2031]:

Country Wise Outlook for the Clobutinol Market

The market for clobutinol has dramatically shifted over the last few years, mainly as a result of safety issues causing its withdrawal from most international markets. Traditionally applied as an antitussive, Clobutinol became very popular, but recent clinical discoveries identified a possible risk of cardiac arrhythmia. These events have had a deeply affecting role in its availability and commercial feasibility, turning it from a ubiquitous over-the-counter or prescription drug into a substance that has very little or no immediate market presence in the majority of developed countries. An appreciation of these changes calls for analyzing particular regulatory measures and active research in the major areas.

Features of the Global Clobutinol Market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Trends & Forecast Analysis

4. Global Clobutinol Market by Type

5. Global Clobutinol Market by Application

6. Regional Analysis

7. North American Clobutinol Market

8. European Clobutinol Market

9. APAC Clobutinol Market

10. ROW Clobutinol Market

11. Competitor Analysis

12. Opportunities & Strategic Analysis

13. Company Profiles of the Leading Players Across the Value Chain

14. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기